NIH Renews Funding for the Antibacterial Resistance Leadership Group
Network Leads Clinical Trials that Address Antibacterial Resistance Threats As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group (ARLG). This global consortium [...]







